New Imaging Technology Could Speed Up Cancer Diagnosis
Early results indicate the process could reduce sample preparation time by approximately 40% to 50%, while improving consistency by removing variability linked to staining conditions.
Read More
Search Results for: lung cancer
Early Lung Cancer Blood Test Completes US Laboratory Validation
The CIZ1B biomarker assay is designed to complement LDCT screening by helping assess lung cancer risk and clarify indeterminate findings.
Read More
Blood-Based Lung Cancer Assay Matches CT Sensitivity in NLST Evaluation
In studies using National Lung Screening Trial biospecimens, a liquid biopsy assay showed similar sensitivity to low-dose CT screening and detected cancers missed by imaging.
Read More
Blood Test Gains FDA Approval for First-Line HER2-Mutant Lung Cancer Treatment Selection
Guardant360 CDx can now identify patients eligible for zongertinib, the first targeted therapy approved as an initial treatment option for HER2-mutant advanced non-small cell lung cancer.
Read More
Liquid Biopsy Maps Tumor Microenvironment to Predict Immunotherapy Response
Mayo Clinic and Stanford Medicine researchers have developed a liquid biopsy that profiles tumor microenvironments to help predict immunotherapy response, according to a study published in Nature.
Read More